Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study
Retrieved on:
Thursday, June 30, 2022
Diagnosis, U.S. News & World Report Best Hospitals Rankings, Science, Patient, CEO, Sichuan University, Liver, Securities Exchange Act of 1934, Research, NGS, Second Affiliated Hospital of Xinjiang Medical University, GLOBE, Cancer, Annual report, Forward-looking statement, Terminology, Hope, Compliance, Fudan University, Policy, Wuhan Union Hospital, Hospital, Technology, Intervention, Lung, Quality of life, SEC, ISBN, Incidence, Medical school, Private Securities Litigation Reform Act, NASDAQ, Pathology, Dalian Medical University, Physician, WCH, Medical imaging, Water Drops on Burning Rocks
The study is led by Dr. Weimin Li, head of the West China Hospital of Sichuan University.
Key Points:
- The study is led by Dr. Weimin Li, head of the West China Hospital of Sichuan University.
- "Cancer early detection, diagnosis and treatment is the key to reducing cancer burden.
- "The PREVENT study is at the cutting edge of cancer early detection and management.
- Yusheng Han, CEO of Burning Rock, remarked that "Multi-cancer early detection through liquid-biopsy is a strategic focus of Burning Rock.